Abstract | BACKGROUND AND PURPOSE: To study whether pre-therapeutic lactate or pyruvate predict for tumour response to fractionated irradiation and to identify possible coherencies between intermediates of glycolysis and expression levels of selected proteins. MATERIALS AND METHODS: RESULTS:
Lactate but not pyruvate concentrations were significantly correlated with tumour response to fractionated irradiation. Lactate concentrations in vivo did not reflect lactate production rates in vitro. Metabolite concentrations did not correlate with GLUT1, PFK-L or LDH-A at the transcriptional or protein level. CD45-positive cell infiltration was low in the majority of tumours and did not correlate with lactate concentration. CONCLUSIONS: Our data support the hypothesis that the antioxidative capacity of lactate may contribute to radioresistance in malignant tumours. Non-invasive imaging of lactate to monitor radiation response and testing inhibitors of glycolysis to improve outcome after fractionated radiotherapy warrant further investigations.
|
Authors | Ulrike G A Sattler, Sandra S Meyer, Verena Quennet, Christian Hoerner, Hannah Knoerzer, Christian Fabian, Ala Yaromina, Daniel Zips, Stefan Walenta, Michael Baumann, Wolfgang Mueller-Klieser |
Journal | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
(Radiother Oncol)
Vol. 94
Issue 1
Pg. 102-9
(Jan 2010)
ISSN: 1879-0887 [Electronic] Ireland |
PMID | 20036432
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright 2009 Elsevier Ireland Ltd. All rights reserved. |
Chemical References |
- Lactic Acid
- Pyruvic Acid
- Adenosine Triphosphate
- Glucose
|
Topics |
- Adenosine Triphosphate
(radiation effects)
- Animals
- Carcinoma, Squamous Cell
(radiotherapy)
- Cell Line, Tumor
- Dose Fractionation, Radiation
- Glucose
(radiation effects)
- Glycolysis
- Head and Neck Neoplasms
(radiotherapy)
- Humans
- Lactic Acid
(radiation effects)
- Mice
- Pyruvic Acid
(radiation effects)
|